Literature DB >> 33797668

Primary Care Providers' Perspectives on Using Automated HIV Risk Prediction Models to Identify Potential Candidates for Pre-exposure Prophylaxis.

Polly van den Berg1, Victoria E Powell2, Ira B Wilson3, Michael Klompas4,5, Kenneth Mayer6,7, Douglas S Krakower6,4,7.   

Abstract

Identifying patients at increased risk for HIV acquisition can be challenging. Primary care providers (PCPs) may benefit from tools that help them identify appropriate candidates for HIV pre-exposure prophylaxis (PrEP). We and others have previously developed and validated HIV risk prediction models to identify PrEP candidates using electronic health records data. In the current study, we convened focus groups with PCPs to elicit their perspectives on using prediction models to identify PrEP candidates in clinical practice. PCPs were receptive to using prediction models to identify PrEP candidates. PCPs believed that models could facilitate patient-provider communication about HIV risk, destigmatize and standardize HIV risk assessments, help patients accurately perceive their risk, and identify PrEP candidates who might otherwise be missed. However, PCPs had concerns about patients' reactions to having their medical records searched, harms from potential breaches in confidentiality, and the accuracy of model predictions. Interest in clinical decision-support for PrEP was greatest among PrEP-inexperienced providers. Successful implementation of prediction models will require tailoring them to providers' preferences and addressing concerns about their use.

Entities:  

Keywords:  Decision support; HIV prevention; Pre-exposure prophylaxis; Primary care; Qualitative research

Year:  2021        PMID: 33797668     DOI: 10.1007/s10461-021-03252-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  1 in total

1.  Pediatric Provider Utilization of a Clinical Decision Support Alert and Association with HIV Pre-exposure Prophylaxis Prescription Rates.

Authors:  Carrie T Chan; Megen Vo; Jennifer Carlson; Tzielan Lee; Marcello Chang; Geoffrey Hart-Cooper
Journal:  Appl Clin Inform       Date:  2022-01-12       Impact factor: 2.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.